"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
President Trump’s proposed tariffs on Denmark could have costly consequences for Americans relying on GLP-1 medications like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback